Dongkook Pharmaceutical Co., Ltd.   Report issue

For profit Phase 1 Phase 3
Founded: Seoul Korea, Republic of (1968)
Status: No NME R&D (1968)

Organization Overview

First Clinical Trial
2013
NCT01942551
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Dongkook Pharmaceutical Co., Ltd.